These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60. Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676 [TBL] [Abstract][Full Text] [Related]
43. Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy. Tai TY; Warner LN; Jones TD; Jung S; Concepcion FA; Skyrud DW; Fender J; Liu Y; Williams AD; Neumaier JF; D'Ambrosio R; Poolos NP Neuroscience; 2017 May; 349():35-47. PubMed ID: 28237815 [TBL] [Abstract][Full Text] [Related]
44. Glucagon protects against impaired NMDA-mediated cerebrovasodilation and cerebral autoregulation during hypotension after brain injury by activating cAMP protein kinase A and inhibiting upregulation of tPA. Armstead WM; Kiessling JW; Cines DB; Higazi AA J Neurotrauma; 2011 Mar; 28(3):451-7. PubMed ID: 21375400 [TBL] [Abstract][Full Text] [Related]
45. Relationship between opioids and prostaglandins in hypoxia-induced vasodilation of pial arteries in the newborn pig. Armstead WM Proc Soc Exp Biol Med; 1996 Jun; 212(2):135-41. PubMed ID: 8650250 [TBL] [Abstract][Full Text] [Related]
46. c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1. Cho JE; Park S; Cho SN; Lee H; Kim YS BMB Rep; 2012 Oct; 45(10):583-8. PubMed ID: 23101513 [TBL] [Abstract][Full Text] [Related]
47. PAN-811 provides neuroprotection against glutamate toxicity by suppressing activation of JNK and p38 MAPK. Chen RW; Lu XC; Yao C; Liao Z; Jiang ZG; Wei H; Ghanbari HA; Tortella FC; Dave JR Neurosci Lett; 2007 Jul; 422(1):64-7. PubMed ID: 17600621 [TBL] [Abstract][Full Text] [Related]
48. Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxic-ischemic brain injury. Hee Han B; Choi J; Holtzman DM Dev Neurosci; 2002; 24(5):405-10. PubMed ID: 12640179 [TBL] [Abstract][Full Text] [Related]
57. Role of altered cyclooxygenase metabolism in impaired cerebrovasodilation to nociceptin/orphanin FQ following brain injury. Armstead WM Brain Res Bull; 2000 Dec; 53(6):807-12. PubMed ID: 11179847 [TBL] [Abstract][Full Text] [Related]
58. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism. Muniyappa H; Das KC Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647 [TBL] [Abstract][Full Text] [Related]
59. Pancreatic stellate cell activation by ethanol and acetaldehyde: is it mediated by the mitogen-activated protein kinase signaling pathway? McCarroll JA; Phillips PA; Park S; Doherty E; Pirola RC; Wilson JS; Apte MV Pancreas; 2003 Aug; 27(2):150-60. PubMed ID: 12883264 [TBL] [Abstract][Full Text] [Related]
60. Clonidine, an alpha-2 adrenoceptor agonist relieves mechanical allodynia in oxaliplatin-induced neuropathic mice; potentiation by spinal p38 MAPK inhibition without motor dysfunction and hypotension. Yeo JH; Yoon SY; Kim SJ; Oh SB; Lee JH; Beitz AJ; Roh DH Int J Cancer; 2016 May; 138(10):2466-76. PubMed ID: 26704560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]